Featured Research

from universities, journals, and other organizations

Greens, B12 May Lower Heart Disease And Cancer Risk

Date:
January 7, 2000
Source:
CSIRO Australia
Summary:
Eating three times the recommended daily intake of folate and vitamin B12 may lower the risk factors for heart disease and cancer, a CSIRO study has found.

Eating three times the recommended daily intake of folate and vitamin B12 may lower the risk factors for heart disease and cancer, a CSIRO study has found.

Folate-rich foods include leafy green vegetables and wholegrains, while B12 is found in meat, chicken, fish, liver and kidneys.

CSIRO Health Sciences and Nutrition scientist, Dr Michael Fenech who led the research says that his team's findings suggest eating more folate and B12 actually slows the wear and tear of DNA - genetic material found in the nucleus in our cells.

"We have found that people with above-average damage to their DNA may reduce some of the damage by boosting their intake of these vitamins," Dr Fenech says.

The results are part of ongoing studies that measure the types and levels of DNA damage in cells' chromosomes among a group of 1000 South Australians.

Dr Fenech is now sharing his results with 40 other scientists in a global study which hopes to provide evidence to link DNA damage with diseases related to age, diet and lifestyle.

"Folate and B12 play a very important role in DNA synthesis and function," says Dr Fenech. "I believe between five and 10 per cent of people eating a Western diet do not take enough to optimise DNA repair and synthesis."

Dr Fenech's studies found wide variations in DNA damage amongst people in similar age groups. This could be due to genetic defects in DNA repair, bad diet or exposure to carcinogens.

Those with above-average rates of DNA damage have two to three times the level of cancer risk than those who have low DNA damage.

The studies found a 25 per cent reduction in chromosome damage amongst the high-damage group, after supplementing their diet for 12 weeks with folate and B12. Those in the low-damage category had no change.

"The message is that it is essential to take care of your DNA, as this should optimise your chances for longevity and reduced cancer risk," Dr Fenech said.

New studies will now determine the optimum level of other vitamins needed to minimise DNA damage.

More information: rosie.schmedding@nap.csiro.au


Story Source:

The above story is based on materials provided by CSIRO Australia. Note: Materials may be edited for content and length.


Cite This Page:

CSIRO Australia. "Greens, B12 May Lower Heart Disease And Cancer Risk." ScienceDaily. ScienceDaily, 7 January 2000. <www.sciencedaily.com/releases/2000/01/000106180103.htm>.
CSIRO Australia. (2000, January 7). Greens, B12 May Lower Heart Disease And Cancer Risk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/01/000106180103.htm
CSIRO Australia. "Greens, B12 May Lower Heart Disease And Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/2000/01/000106180103.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins